In this work, we provided the unprecedent findings that BRAFV600E CRC subjects, who did not undergo any type of treatment, might be discriminated from the other CRC’s cases in terms of their microbial composition, being closer to healthy condition than BRAF wild-type cases. This evidence concerns the gene BRAF and colorectal carcinoma.